Phenylephrine Hydrochloride Injection
NDC Package 71839-129-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Phenylephrine Hydrochloride injection is 10 mg/mL is indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation in the settings of anesthesia and septic shock. This formulation utilizes a injection delivery system. Marketed by Be Pharmaceuticals Inc., this product is identified by NDC 71839-129 and is authorized under FDA application ANDA217521.

Identification & Billing

NDC Package Code
71839-129-10
Package Description
10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 10 mL in 1 VIAL, PHARMACY BULK PACKAGE (71839-129-01)
Product Code
71839-129
11-Digit Billing Format
71839012910
RxNorm Crosswalk
  • RxCUI: 1232651 - phenylephrine HCl 10 MG/ML Injectable Solution
  • RxCUI: 1232651 - phenylephrine hydrochloride 10 MG/ML Injectable Solution
  • RxCUI: 1232651 - phenylephrine hydrochloride 1 % Injectable Solution
  • RxCUI: 1232651 - phenylephrine hydrochloride 100 MG per 10 ML Injectable Solution
  • RxCUI: 1232651 - phenylephrine hydrochloride 50 MG per 5 ML Injectable Solution

Clinical Specifications

Proprietary Name
Phenylephrine Hydrochloride
Non-Proprietary Name
Phenylephrine Hydrochloride
Substance Name
Phenylephrine Hydrochloride
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
PHENYLEPHRINE HYDROCHLORIDE 10 mg/mL
Pharmacologic Class
Usage Information
Phenylephrine Hydrochloride Injection 10 mg/mL is indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation in the settings of anesthesia and septic shock.

Regulatory & Marketing

Labeler Name
Be Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA217521
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-10-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71839-129-10 identifies a specific commercial package of 10 vial, pharmacy bulk package in 1 carton / 10 ml in 1 vial, pharmacy bulk package (71839-129-01) of Phenylephrine Hydrochloride, a human prescription drug labeled by Be Pharmaceuticals Inc.. This injection is formulated for intravenous use and contains phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Be Pharmaceuticals Inc. on July 10, 2023. The current certification is valid through December 31, 2026.

How is this Be Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71839012910. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71839-129-10
11-Digit CMS (5-4-2)
71839-0129-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.